REVELES XAVIER TRINIDAD enters BIOAFFINITY TECHNOLOGIES, INC. with 3.62K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/25/2023ACC: 0001493152-23-033613
Officer· Chief Operating Officer
Since Sep 2023
3.62K
Baseline shares
100% direct
3.62K
Direct ownership
1 position
7.86K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned3.62K
Total
3.62K direct3.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.62K | Direct |
| Total | 3.62K | 3.62K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common stock
Underlying shares
1.43K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
2.14K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
1.43K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
2.86K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Total
Underlying
7.86K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common stock | 7.70 | — | — | 1.43K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.70 | — | — | 2.14K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.70 | — | — | 1.43K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.70 | — | — | 2.86K | N/A |
| Total | 7.86K | 0.00 | ||||